Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 14, 2014 - Issue 2
Submit an article Journal homepage
150
Views
5
CrossRef citations to date
0
Altmetric
Special Report

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

Yara D FragosoMS Reference Center, Medical School, Universidade Metropolitana de Santos, Santos, SP, Brazil;Department of Neurology, Medical School, Universidade Metropolitana de Santos, Rua da Constituicao 374, CEP 11015-470, Santos, SP, BrazilCorrespondence[email protected]
,
Niedja M ArrudaDemyelinating Diseases Reference Center, Hospital da Restauração, Recife, PE, Brazil
,
Walter O ArrudaMS Unit, Medical School, Universidade Federal do Paraná, Curitiba, PR, Brazil
,
Joseph BB BrooksMS Reference Center, Medical School, Universidade Metropolitana de Santos, Santos, SP, Brazil
,
Eber C CorreaMS Unit, CLINEN – Neurologia e Endocrinologia, Brasília, DF, Brazil
,
Alfredo DamascenoMS Reference Center, Medical School, Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Carlos A DamascenoMS Unit, Medical School, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil
,
Maria LB FerreiraDemyelinating Diseases Reference Center, Hospital da Restauração, Recife, PE, Brazil
,
Maria CB GiacomoMS Unit, Holus Medical Services, São Paulo, SP, Brazil
,
Sidney GomesMS Unit, Hospital Beneficência Portuguesa and Hospital Paulistano, São Paulo, SP, Brazil
,
Marcus VM GonçalvesMS Unit, Centro Hospitalar Unimed, Joinville, SC, Brazil
,
Anderson K GrzesiukMS Reference Center, Centro de Reabilitação Dom Aquino Correa, Cuiaba, MT, Brazil
,
Damacio R Kaimen-MacielMS Reference Center, Medical School, Universidade Estadual de Londrina, Londrina, PR, Brazil
,
Josiane LopesMS Reference Center, Medical School, Universidade Estadual de Londrina, Londrina, PR, Brazil
,
Suzana CN MachadoMS Reference Center, Imperial Hospital de Caridade, Hospital Governador Celso Ramos, Florianopolis, SC, Brazil
,
Celso LS OliveiraMS Reference Center, Medical School, Universidade Metropolitana de Santos, Santos, SP, Brazil
&
Carla RAV StellaMS Unit, Neurology, Campinas, SP, Brazil
 show all
Pages 127-130 | Published online: 13 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon, Samira Luisa Apostolos-Pereira, Yuna Ribeiro de Araujo, Jefferson Becker, Joseph Bruno Bidin Brooks, Eber Castro Correa, Alfredo Damasceno, Carlos Augusto de Albuquerque Damasceno, Maria Lucia B. Ferreira, Paulo Diniz da Gama, Rodrigo Assad Diniz da Gama, Sidney Gomes, Marcus Vinicius Magno Goncalves, Anderson Kuntz Grzesiuk, Suzana Costa Nunes Machado, Andre Palma da Cunha Matta, Maria Fernanda Mendes, Taysa Alexandrino Goncalves Jube Ribeiro, Cristiane Franklin da Rocha, Heloisa Helena Ruocco, Henry Sato, Renata Faria Simm, Carlos Bernardo Tauil, Claudia Cristina Ferreira Vasconcelos & Vera Lucia Ferreira Vieira. (2016) Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis. Expert Review of Clinical Pharmacology 9:4, pages 541-546.
Read now

Articles from other publishers (4)

Aurora Zanghì, Antonio Gallo, Carlo Avolio, Rocco Capuano, Matteo Lucchini, Maria Petracca, Simona Bonavita, Roberta Lanzillo, Diana Ferraro, Erica Curti, Maria Buccafusca, Graziella Callari, Stefania Barone, Giuseppe Pontillo, Gianmarco Abbadessa, Valeria Di Francescantonio, Elisabetta Signoriello, Giacomo Lus, Patrizia Sola, Franco Granella, Paola Valentino, Massimiliano Mirabella, Francesco Patti & Emanuele D’Amico. (2021) Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study. Neurotherapeutics 18:2, pages 1166-1174.
Crossref
Peter Alping, Thomas Frisell, Lenka Novakova, Protik Islam-Jakobsson, Jonatan Salzer, Anna Björck, Markus Axelsson, Clas Malmeström, Katharina Fink, Jan Lycke, Anders Svenningsson & Fredrik Piehl. (2016) Rituximab versus fingolimod after natalizumab in multiple sclerosis patients. Annals of Neurology 79:6, pages 950-958.
Crossref
Rosy N’gbo N’gbo Ikazabo, Christian Mostosi, Bénédicte Quivron, Xavier Delberghe, Kaoutar El Hafsi & Andreas P. Lysandropoulos. (2016) Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases. Clinical Therapeutics 38:3, pages 670-675.
Crossref
Yara Dadalti Fragoso. (2014) Modifiable environmental factors in multiple sclerosis. Arquivos de Neuro-Psiquiatria 72:11, pages 889-894.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.